Table: Brightpath Biotherapeutics - 9-MTH parent results

BrightPath Biotherapeutics Co

09/02/2024 06:00

Feb 9 (Reuters)- 
             Brightpath Biotherapeutics Co., Ltd. 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2023        Dec 31, 2022      Mar 31, 2024  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales             0 mln               5 mln             0 mln     
                 (-98.7 pct)                           (-98.7 pct)  
  Operating     loss 947 mln          loss 1.22         loss 1.59   
  Recurring     loss 947 mln          loss 1.22         loss 1.59   
  Net           loss 953 mln          loss 1.23         loss 1.59   
  EPS          loss 15.14 yen      loss 20.91 yen    loss 24.04 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T